| Literature DB >> 26949039 |
Wei Zhang1, Kuen-Phon Wu2, Maria A Sartori1, Hari B Kamadurai2, Alban Ordureau3, Chong Jiang4, Peter Y Mercredi2, Ryan Murchie4, Jicheng Hu5, Avinash Persaud4, Manjeet Mukherjee2, Nan Li6, Anne Doye7, John R Walker5, Yi Sheng8, Zhenyue Hao9, Yanjun Li5, Kevin R Brown1, Emmanuel Lemichez7, Junjie Chen6, Yufeng Tong10, J Wade Harper3, Jason Moffat11, Daniela Rotin4, Brenda A Schulman12, Sachdev S Sidhu13.
Abstract
HECT-family E3 ligases ubiquitinate protein substrates to control virtually every eukaryotic process and are misregulated in numerous diseases. Nonetheless, understanding of HECT E3s is limited by a paucity of selective and potent modulators. To overcome this challenge, we systematically developed ubiquitin variants (UbVs) that inhibit or activate HECT E3s. Structural analysis of 6 HECT-UbV complexes revealed UbV inhibitors hijacking the E2-binding site and activators occupying a ubiquitin-binding exosite. Furthermore, UbVs unearthed distinct regulation mechanisms among NEDD4 subfamily HECTs and proved useful for modulating therapeutically relevant targets of HECT E3s in cells and intestinal organoids, and in a genetic screen that identified a role for NEDD4L in regulating cell migration. Our work demonstrates versatility of UbVs for modulating activity across an E3 family, defines mechanisms and provides a toolkit for probing functions of HECT E3s, and establishes a general strategy for systematic development of modulators targeting families of signaling proteins.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26949039 PMCID: PMC4988125 DOI: 10.1016/j.molcel.2016.02.005
Source DB: PubMed Journal: Mol Cell ISSN: 1097-2765 Impact factor: 17.970